M4P for National Malaria Programme (2010-2015)

Tap image to view

Client

DFID

Project Location

Project Duration

6 years

Total Value

£89m

Value of Montrose Component

£1.6m

Situation

  • Health indicators in Nigeria are some of the worst in the world and malaria is a key factor.
  • In 2008 malaria accounted for 60% of outpatient visits and 30% of deaths in children under five.
  • Malaria was a major cause of absenteeism and low productivity.
  • Inadequate funding and weak health systems limited the roll-out of prevention and treatment measures.
  • Modest anti-malaria initiatives being implemented were not optimised due to lack of appropriate health seeking behaviour among the Nigerian population.

Solution

  • Montrose was contracted to oversee the commercial sector component of the Support to National Malaria programme (SuNMaP), and apply a Making Markets Work for the Poor (M4P) approach.
  • Interventions included:
    • Development of commercial sector engagement strategies to develop markets for long-lasting insecticidal nets (LLIN).
    • Rapid diagnostic tests (RDTs) and artemisinin combination therapies (ACTs).
    • Training of ‘market support officers’ on practical application of M4P approaches.
    • Design of an access to finance initiative for LLIN importers and distributors.
    • Demand creation interventions for RDTs including a feasibility study on subsidies.

Impact

  • M4P targeted the removal of market bottlenecks and enhancement of market systems for antimalaria commodities.
  • A cumulative total of 2.2 million nets were sold through the commercial sector.
  • In 2014, the Standardised Monitoring and Assessment of Relief and Transitions survey found that:
    • Households with least one LLIN increased from 8% to 53%.
    • Children under five years sleeping under LLINs increased from 6% to 25%.
  • In 2013, the Nigeria Demographic and Health Survey found that:
    • Children under five with fever treated with ACTs increased from 2.4% to 5.9%.
    • Under‐five mortality rate decreased from 157 per 1,000 to 128 per 1,000.